Does CABOZANTINIB Cause Hyponatraemia? 91 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Hyponatraemia have been filed in association with CABOZANTINIB. This represents 2.4% of all adverse event reports for CABOZANTINIB.
91
Reports of Hyponatraemia with CABOZANTINIB
2.4%
of all CABOZANTINIB reports
13
Deaths
82
Hospitalizations
How Dangerous Is Hyponatraemia From CABOZANTINIB?
Of the 91 reports, 13 (14.3%) resulted in death, 82 (90.1%) required hospitalization, and 9 (9.9%) were considered life-threatening.
Is Hyponatraemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB. However, 91 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB Cause?
Diarrhoea (404)
Fatigue (263)
Malignant neoplasm progression (238)
Nausea (215)
Decreased appetite (191)
Off label use (190)
Hypertension (165)
Pyrexia (162)
Vomiting (157)
Asthenia (153)
What Other Drugs Cause Hyponatraemia?
FUROSEMIDE (3,127)
HYDROCHLOROTHIAZIDE (2,138)
OMEPRAZOLE (1,635)
LANSOPRAZOLE (1,416)
SERTRALINE (1,332)
RAMIPRIL (1,178)
SPIRONOLACTONE (1,166)
PANTOPRAZOLE (1,134)
INDAPAMIDE (976)
AMLODIPINE (879)
Which CABOZANTINIB Alternatives Have Lower Hyponatraemia Risk?
CABOZANTINIB vs CABOZANTINIB S-MALATE
CABOZANTINIB vs CAFFEINE
CABOZANTINIB vs CALASPARGASE PEGOL
CABOZANTINIB vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB vs CALCIFEDIOL